the financial support from the National Natural Science Foundation of China(No.31972040,81760708);Jiangxi Provincial Natural Science Foundation Key Project(No.20192ACBL20028,China)。
Immunotherapy combined with effective therapeutics such as chemotherapy and photodynamic therapy have been shown to be a successful strategy to activate anti-tumor immune responses for improved anticancer treatment.Ho...
supported by the National Natural Science Foundation of China(Nos.22090011,22078046,21808028);NSFC Liaoning United Fund(No.U1908202)。
During cancer treatment,chemotherapeutic drugs always result in severe side-effects and drug resistance.Therefore,combining cheomtherapy with other therapeutic modalities,such as photodynamic therapy(PDT)and designing...
supported by the Natural Science Foundation of China (Grant Nos. 52022090, 22005265, 82070739, 81870641);National Key R&D Program of China (Grant No. 2018YFC1106104);Key Research and Development Program of Zhejiang Province (Grant No. 2020C03035);Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ20E030011);Zhejiang Medical Health Science and Technology Program (Grant No. 2021RC061);Zhejiang Provincial Ten Thousand Talents Program (2018R52001)。
Gemcitabine has been extensively applied in treating various solid tumors. Nonetheless,the clinical performance of gemcitabine is severely restricted by its unsatisfactory pharmacokinetic parameters and easy deactivat...
Potassium 2-(1-hydroxypentyl)-benzoate (d/-PHPB) is a novel pro-drug of 3-n-butylphthalide (dkNBP) that is used to treat ischemic stroke. Currently, dl-PHPB is in phase II-III clinical trials in China. In this s...
BACKGROUND: Propofol has been shown to attenuate neuronal injury in a number of experimental conditions. However, its effect in models of cerebral ischemia after subarachnoid hemorrhage (SAH) remains controversial....
Supported by National Natural Science Foundation of China, No.30472038; Department of Science and Technology of Shandong Province, China and Japan-China Medical Association
AIM: To evaluate the growth inhibition efficacy of atofluding derivative N3-o-toluyl-fluorouracil (TFU) on human gastric carcinoma cell lines SGC-7901 and MKN-45. METHODS: Cell growth inhibition by TFU was measure...